Optiscan Signs Know-How Agreement with Mayo Clinic
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 13 2024
0mins
Source: businesswire
- Collaboration Announcement: Optiscan Imaging Limited has partnered with Mayo Clinic to develop a digital confocal laser endomicroscopic imaging system for robotic surgery, focusing on breast cancer surgery.
- Market Growth: The robotic-assisted surgery market is rapidly expanding due to technological advancements, increased adoption, and rising chronic diseases, with the US market expected to grow significantly by 2030.
- Strategic Focus: Optiscan aims to embed its technology in oncological surgery workflows in the US to provide real-time microscopic information for cancer clearance and reduce repeat surgeries.
- Mayo Clinic's Role: Mayo Clinic, known for high-quality patient care, will collaborate with Optiscan and use any revenue from the technology to support its not-for-profit mission.
- About Optiscan: Optiscan Imaging Ltd specializes in confocal endomicroscopic imaging technologies for medical applications, focusing on early disease detection and improving patient outcomes.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
